The global Clinical Mass Spectrometry market was valued at US$ 760.3 million in 2020 and is expected to reach US$ 1478.5 million by the end of 2027, growing at a CAGR of 10.0% during 2021-2027.
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics. Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
Global clinical mass spectrometry key players include AB Sciex (Danaher), Bruker, Thermo Fisher, Agilent, Waters, etc. Global top 5 manufacturers hold a share about 85%. North America is the largest market, with a share about 40%, followed by Europe, with a share about 30 percent.
Global Clinical Mass Spectrometry Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Clinical Mass Spectrometry Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are AB Sciex (Danaher), Bruker, Thermo Fisher, Agilent, Waters, Perkin Elmer, Shidmazu and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Find more details at: https://www.themarketreports.com/report/global-clinical-mass-spectrometry-market-outlook
Segment by Type
Segment by Application
- Clinical Diagnostics
- Clinical Research
Table of Content:
1 Clinical Mass Spectrometry Market Overview
2 Clinical Mass Spectrometry Market Competition by Manufacturers
3 Clinical Mass Spectrometry Retrospective Market Scenario by Region
4 Global Clinical Mass Spectrometry Historic Market Analysis by Type
5 Global Clinical Mass Spectrometry Historic Market Analysis by Application
6 Key Companies Profiled
7 Clinical Mass Spectrometry Manufacturing Cost Analysis
8 Marketing Channel, Distributors and Customers
9 Clinical Mass Spectrometry Market Dynamics
10 Global Clinical Mass Spectrometry Market Forecast
11 Research Finding and Conclusion
12 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta